Effects of VLCKD in Metabolic Syndrome

Condition(s) studied

Investigational drug(s) / intervention(s)

VLCKD diet with replacing meals: Patients will receive an accurate teaching + brochure on VLCKD diet from an expert dietician and freely receive the correct amount of supplements provided from Labotaoire Therascience (4 or 5 meals). The supplements contain (in total) between 600 and 800 kcal, mainly fats, 1,2/1,5 g/body weight of proteins, very low amount of charbohydrates (\<30/40g/die), 10-20g fibers, + minerals and vitamins covering the needings of patients. After 6-8 weeks, 1 meal will be replaced with a natural dish rich in proteins.

Hypocaloric mediterranean Diet: Patients will receive an accurate teaching + brochure on an hypocaloric Mediterranean style diet (LARN 2014) from an expert dietician. Patients will follow the istructions on grams and foods to eat. The calories will be around minus 400-500 kcal from energy requirement (measured by indirect calorimetry \* physical activity score).

Study summary

VLCKD has showed to be an impactful diet on several metabolism aspects and has proven to be useful for preventing and treating diabetes mellitus type 2, overweight, chronic inflammation and fatty liver.

For this reason, the aim of this pilot study is to examinate the potential effect of a VLCKD on a group of patients that contemporarily have DM2, obesity and Non alcholic fatty liver disease (NAFLD), comparing the results with an ipocaloric diet based on Mediterranean Principles and Italian LARN (SINU 2014).

This study will consider several interrelated outcomes such as anthropometric data, hematochemical and hormonal parameters, questionnaires, stool microbiota and omics, blood microvescicles, urine tests, instrumental tests (DXA, BIVA, ecographies), biopses and functional tests.

40 subjects will be evaluated and divided in two groups of 20 (VLCKD) and 20 (MedDiet).

Eligibility

Primary outcome measure(s)

• Change in weight — Change from Baseline BMI at 15 days, 30 days, 60 days, 90 days
  Variation of body weight assessed through body mass index change (BMI)(kg/m2)
• Change in body circumferences — Change from Baseline circumferences at 15 days, 30 days, 60 days, 90 days
  Variation of body circumferences (waist, hips)
• Change in metabolic control — Change from Baseline blood glucose at 15 days, 30 days, 60 days, 90 days
  Variation of blood glucose
• Change in metabolic control — Change from Baseline lipid profile at 15 days, 30 days, 60 days, 90 days
  Change of cardio-metabolic risk factors: lipid profile

Trial sites (1)

More Azienda Ospedaliero Universitaria Maggiore della Carita trials in Italy

Other trials for the same condition